CAMMA', Calogero
CAMMA', Calogero
Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”
751 RETINOL-BINDING PROTEIN 4 (RBP4): A NEW MARKER OF G1 HCV-INDUCED STEATOSIS
2008-01-01 PETTA S; CAMMA C; DI MARCO V; BARBARIA F; CABIBI D; CALDARELLA R; CIMINNISI S; LICATA A; MASSENTI MF; MAZZOLA A; TARANTINO G; MARCHESINI G; CRAXI A
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma.
2010-01-01 Cabibbo, G; Enea, M; Attanasio, M; Bruix, J; Craxì, A; Cammà, C.
The aetiological pattern of hepatocellular carcinoma ( HCC) in Italy is changing
2004-01-01 DI MARCO, V; PARISI, P; ALIZZI, S; ALAIMO, G; SANDONATO, L; PARDO, S; CABIBI, D; ALMASIO, P; LICATA, A; CAMMA', C; LATTERI, M; CRAXI', A
Aminopyrine breath test predicts liver-related events and death in HCV-related cirrhosis on SVR after DAA therapy
2019-01-01 Petta S.; Rini F.; Calvaruso V.; Camma C.; Ciminnisi S.; Di Marco V.; Giannini E.G.; Grimaudo S.; Maria Pipitone R.; Craxi A.
Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization?
2021-01-01 Celsa C.; Cabibbo G.; Enea M.; Battaglia S.; Rizzo G.E.M.; Busacca A.; Giuffrida P.; Stornello C.; Brancatelli G.; Cannella R.; Gruttadauria S.; Cammà Calogero.
Assessment of treatment response in hepatocellular carcinoma: a review of literature
2013-01-01 Maida, M; Cabibbo, G; Brancatelli, G; Genco, C; Alessi, N; Genova, C; Romano, P; Raineri, M; Giarratano, A; Midiri, M; Cammà, C.
Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease
2020-01-01 Grimaudo, Stefania; Pipitone, Rosaria Maria; Pennisi, Grazia; Celsa, Ciro; Cammà, Calogero; Di Marco, Vito; Barcellona, Maria Rosa; Boemi, Roberta; Enea, Marco; Giannetti, Aurora; Spatola, Federica; Marchesini, Giulio; Craxì, Antonio; Petta, Salvatore
Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients
2013-01-01 Petta, S; Grimaudo, S; Di Marco, V; Scazzone, C; Macaluso, F; Cammà, C; Cabibi, D; Pipitone, R; Craxì, A
Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women
2014-01-01 Bernabucci, V.; Ciancio, A.; Petta, S.; Karampatou, A.; Turco, L.; Strona, S.; Critelli, R.; Todesca, P.; Cerami, C.; Sagnelli, C.; Rizzetto, M.; Cammà, C.; Villa, E.
Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection
2013-01-01 Macaluso, F; Maida, M; Cammà, C; Cabibi, D; Alessi, N; Cabibbo, G; Di Marco, V; Craxì, A; Petta, S
Can chemotherapy concomitantly delivered with radiotherapy improve survival of patients with resectable rectal cancer? A meta-analysis of literature data
2010-01-01 Fiorica, F; Cartei, F; Licata, A; Enea, M; Ursino, S; Colosimo, C; Cammà, C
Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis
2016-01-01 Licata, A; Novo, G; Colomba, D; Tuttolomondo, A; Galia, M; Camma', C
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations.
2011-01-01 Petta, S; Torres, D; Fazio, G; Cammà, C; Cabibi, D; Di Marco, V; Licata, A; Marchesini, G; Mazzola, A; Parrinello, G; Novo, S; Licata, G; Craxì, A.
Causes of and prevention strategies for hepatocellular carcinoma.
2012-01-01 Cabibbo, G; Maida, M; Genco, C; Antonucci, M; Cammà, C
Chemoprevention for hepatocellular carcinoma: the role of statins
2013-01-01 Cabibbo, G; Petta, S; Cammà, C
Chemoprevention of hepatocellular carcinoma.
2006-01-01 CRAXI' A; SCHEPIS F; CAMMA' C
A cholestatic pattern predicts major liver-related outcomes in patients with non-alcoholic fatty liver disease
2022-03-04 Grazia Pennisi, Rosaria Maria Pipitone, Daniela Cabibi, Marco Enea, Manuel Romero-Gomez, Mauro Viganò, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Anna Ludovica Fracanzani, Giada Sebastiani, Annalisa Berzigotti, Francesca Di Salvo, Antonino Giulio Giannone, Claudia La Mantia, Giulia Lupo, Rossana Porcasi, Federica Vernuccio, Rossella Zito, Vito Di Marco, Calogero Cammà, Antonio Craxì, Victor de Ledinghen, Stefania Grimaudo, Salvatore Petta
Clinical implications of the hyperdynamic syndrome in cirrhosis.
2014-01-01 Licata, A; Mazzola, A; Ingrassia, D; Calvaruso, V; Cammà, C; Craxì, A
Clinical trial: High-dose furosemide plus small-volume hypertonic saline solutions vs. repeated paracentesis as treatment of refractory ascites.
2009-01-01 Licata, G; Tuttolomondo, A; Licata, A; Parrinello, G; Di Raimondo, D; Di Sciacca, R; Cammà, C; Craxì, A; Paterna, S; Pinto, A
The combination of liver stiffness measurement and NAFLD fibrosis score improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with nonalcoholic fatty liver disease.
2015-01-01 Petta, S; Vanni, E; Bugianesi, E; Di Marco, V; Cammà, C; Cabibi, D; Mezzabotta, L; Craxì, A